loadpatents
name:-0.06053900718689
name:-0.037381887435913
name:-0.0013549327850342
Bhagat; Lakshmi Patent Filings

Bhagat; Lakshmi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bhagat; Lakshmi.The latest application filed is for "galnac cluster phosphoramidite and targeted therapeutic nucleosides".

Company Profile
0.43.49
  • Bhagat; Lakshmi - Framingham MA
  • Bhagat; Lakshmi - Cambridge MA
  • Bhagat; Lakshmi - Brookline MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Galnac Cluster Phosphoramidite And Targeted Therapeutic Nucleosides
App 20220298508 - Zhang; Jason ;   et al.
2022-09-22
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20170145417 - Kandimalla; Ekambar R. ;   et al.
2017-05-25
Compositions For Inhibiting Nlrp3 Gene Expression And Uses Thereof
App 20170145412 - Jiang; Weiwen ;   et al.
2017-05-25
Compositions For Inhibiting Dux4 Gene Expression And Uses Thereof
App 20170009230 - Agrawal; Sudhir ;   et al.
2017-01-12
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,453,228 - Kandimalla , et al. September 27, 2
2016-09-27
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160138022 - Kandimalla; Ekambar R. ;   et al.
2016-05-19
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,206,430 - Kandimalla , et al. December 8, 2
2015-12-08
Stabilized immunomodulatory oligonucleotides
Grant 8,946,175 - Kandimalla , et al. February 3, 2
2015-02-03
Toll like receptor modulators
Grant 8,853,375 - Kandimalla , et al. October 7, 2
2014-10-07
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20130267583 - Kandimalla; Ekambar R. ;   et al.
2013-10-10
Compositions for inhibiting gene expression and uses thereof
Grant 8,431,544 - Agrawal , et al. April 30, 2
2013-04-30
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,426,375 - Kandimalla , et al. April 23, 2
2013-04-23
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,399,423 - Kandimalla , et al. March 19, 2
2013-03-19
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,383,598 - Kandimalla , et al. February 26, 2
2013-02-26
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,377,898 - Kandimalla , et al. February 19, 2
2013-02-19
Synthetic agonists of TLR9
Grant 8,361,986 - Kandimalla , et al. January 29, 2
2013-01-29
Stabilized immune modulatory RNA (SIMRA) compounds
Grant 8,362,233 - Kandimalla , et al. January 29, 2
2013-01-29
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,357,665 - Kandimalla , et al. January 22, 2
2013-01-22
Modulation Of Immunostimulatory Properties Of Oligonucleotide-based Compounds By Utilizing Modified Immunostimulatory Dinucleotides
App 20120201807 - Agrawal; Sudhir ;   et al.
2012-08-09
Stabilized Immune Modulatory Rna (simra) Compounds
App 20120183530 - Kandimalla; Ekambar ;   et al.
2012-07-19
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 8,202,850 - Agrawal , et al. June 19, 2
2012-06-19
Stabilized immune modulatory RNA (SIMRA) compounds
Grant 8,188,261 - Kandimalla , et al. May 29, 2
2012-05-29
Modulation of toll-like receptor 5 expression by antisense oligonucleotides
Grant 8,153,777 - Kandimalla , et al. April 10, 2
2012-04-10
Modulation of toll-like receptor 3 expression by antisense oligonucleotides
Grant 8,153,605 - Kandimalla , et al. April 10, 2
2012-04-10
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Grant 8,153,608 - Agrawal , et al. April 10, 2
2012-04-10
Compositions For Inhibiting Gene Expression And Uses Thereof
App 20120016004 - AGRAWAL; SUDHIR ;   et al.
2012-01-19
Novel Synthetic Agonists Of Tlr9
App 20110311518 - KANDIMALLA; EKAMBAR R. ;   et al.
2011-12-22
Novel Synthetic Agonists Of Tlr9
App 20110293565 - Kandimalla; Ekambar ;   et al.
2011-12-01
Modulation Of Immunostimulatory Properties Of Oligonucleotide-based Compounds By Optimal Presentation Of 5' Ends
App 20110229456 - AGRAWAL; SUDHIR ;   et al.
2011-09-22
Stabilized immunomodulatory oligonucleotides
Grant 8,008,267 - Kandimalla , et al. August 30, 2
2011-08-30
Modulation Of Immunostimulatory Properties Of Oligonucleotide-based Compounds By Utilizing Modified Immunostimulatory Dinucleotides
App 20110150863 - Agrawal; Sudhir ;   et al.
2011-06-23
Synthetic agonists of TLR9
Grant 7,960,362 - Kandimalla , et al. June 14, 2
2011-06-14
Synthetic Agonists Of Tlr9
App 20110135669 - KANDIMALLA; EKAMBAR ;   et al.
2011-06-09
Compositions For Inhibiting Gene Expression And Uses Thereof
App 20110082186 - Agrawal; Sudhir ;   et al.
2011-04-07
Synthetic agonists of TLR9
Grant 7,884,197 - Kandimalla , et al. February 8, 2
2011-02-08
Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
Grant 7,875,594 - Kandimalla , et al. January 25, 2
2011-01-25
Oligonucleotide-based Compounds As Inhibitors Of Toll-like Receptors
App 20110009477 - Yu; Dong ;   et al.
2011-01-13
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Grant 7,863,250 - Agrawal , et al. January 4, 2
2011-01-04
Short immunomodulatory oligonucleotides
Grant 7,851,454 - Agrawal , et al. December 14, 2
2010-12-14
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Grant 7,851,453 - Agrawal , et al. December 14, 2
2010-12-14
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,812,000 - Agrawal , et al. October 12, 2
2010-10-12
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
App 20100254974 - Agrawal; Sudhir ;   et al.
2010-10-07
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,749,975 - Agrawal , et al. July 6, 2
2010-07-06
Modulation of Toll-Like Receptor 2 Expression By Antisense Oligonucleotides
App 20100111935 - Bhagat; Lakshmi ;   et al.
2010-05-06
Modulation of Toll-Like Receptor 5 Expression by Antisense Oligonucleotides
App 20100111937 - Kandimalla; Ekambar ;   et al.
2010-05-06
Modulation of Toll-Like Receptor 4 Expression by Antisense Oligonucleotides
App 20100111936 - Putta; Mallikarjuna ;   et al.
2010-05-06
Modulation Of Myeloid Differentation Primary Response Gene 88 (myd88) Expression By Antisense Oligonucleotides
App 20100092486 - Kandimalla; Ekambar ;   et al.
2010-04-15
Modulation Of Toll-like Receptor 8 Expression By Antisense Oligonucleotides
App 20100047188 - Kandimalla; Ekambar ;   et al.
2010-02-25
Modulation Of Toll-like Receptor 3 Expression By Antisense Oligonucleotides
App 20100041735 - Kandimalla; Ekambar ;   et al.
2010-02-18
Modulation Of Toll-like Receptor 7 Expression By Antisense Oligonucleotides
App 20100041734 - Kandimalla; Ekambar ;   et al.
2010-02-18
Modulation Of Toll-like Receptor 9 Expression By Antisense Oligonucleotides
App 20100035967 - Kandimalla; Ekambar ;   et al.
2010-02-11
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Grant 7,632,822 - Agrawal , et al. December 15, 2
2009-12-15
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Grant 7,595,305 - Agrawal , et al. September 29, 2
2009-09-29
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
Grant 7,569,554 - Kandimalla , et al. August 4, 2
2009-08-04
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20090098063 - Kandimalla; Ekambar R. ;   et al.
2009-04-16
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,517,862 - Agrawal , et al. April 14, 2
2009-04-14
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20090087388 - Kandimalla; Ekambar ;   et al.
2009-04-02
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20090081198 - Kandimalla; Ekambar ;   et al.
2009-03-26
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
App 20090060898 - Kandimalla; Ekambar R. ;   et al.
2009-03-05
Stabilized Immune Modulatory Rna (simra) Compounds
App 20090053205 - Kandimalla; Ekambar ;   et al.
2009-02-26
Novel Synthetic Agonists Of Tlr9
App 20090053206 - Kandimalla; Ekambar R. ;   et al.
2009-02-26
Toll Like Receptor Modulators
App 20090053148 - Kandimalla; Ekambar ;   et al.
2009-02-26
Short Immunomodulatory Oligonucleotides
App 20090010938 - Agrawal; Sudhir ;   et al.
2009-01-08
Synthetic Agonists Of Tlr9
App 20080292648 - Kandimalla; Ekambar ;   et al.
2008-11-27
Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications
App 20080279785 - Kandimalla; Ekambar R. ;   et al.
2008-11-13
Synergistic Treatment Of Cancer Using Immunomers In Conjunction With Chemotherapeutic Agents
App 20080206265 - Kandimalla; Ekambar R. ;   et al.
2008-08-28
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,407,944 - Agrawal , et al. August 5, 2
2008-08-05
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20080152662 - Agrawal; Sudhir ;   et al.
2008-06-26
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20080089883 - Kandimalla; Ekambar R. ;   et al.
2008-04-17
Short immunomodulatory oligonucleotides
Grant 7,354,907 - Agrawal , et al. April 8, 2
2008-04-08
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,276,489 - Agrawal , et al. October 2, 2
2007-10-02
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20070173469 - Agrawal; Sudhir ;   et al.
2007-07-26
Short immunomodulatory oligonucleotides
App 20070093439 - Agrawal; Sudhir ;   et al.
2007-04-26
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
App 20060287261 - Agrawal; Sudhir ;   et al.
2006-12-21
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20060287262 - Agrawal; Sudhir ;   et al.
2006-12-21
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
App 20060211641 - Agrawal; Sudhir ;   et al.
2006-09-21
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20060019909 - Agrawal; Sudhir ;   et al.
2006-01-26
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
App 20060019918 - Agrawal; Sudhir ;   et al.
2006-01-26
Stabilized immunomodulatory oligonucleotides
App 20050026861 - Kandimalla, Ekambar R. ;   et al.
2005-02-03
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
App 20040198685 - Agrawal, Sudhir ;   et al.
2004-10-07
Short immunomodulatory oligonucleotides
App 20040156825 - Agrawal, Sudhir ;   et al.
2004-08-12
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20040097719 - Agrawal, Sudhir ;   et al.
2004-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed